Phase II Evaluation of Oral Estramustine, Oral Etoposide, and Intravenous Paclitaxel in Patients with Hormone-Sensitive Prostate Adenocarcinoma (Q57714746)
Jump to navigation
Jump to search
scientific article published on 01 June 2007
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase II Evaluation of Oral Estramustine, Oral Etoposide, and Intravenous Paclitaxel in Patients with Hormone-Sensitive Prostate Adenocarcinoma |
scientific article published on 01 June 2007 |
Statements
Phase II evaluation of oral estramustine, oral etoposide, and intravenous paclitaxel in patients with hormone-sensitive prostate adenocarcinoma (English)
Niklas J Mackler
Rodney L Dunn
Bruce G Redman
Karin B Olson